# Kai-Fu Lee

> Kai-Fu Lee is a Series B investor at Sinovation Ventures backing Medical. See 14 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Sinovation Ventures](https://shizune.co/investors/profile/sinovation-ventures)
- Location: Beijing, China
- Total investments: 14
- Last investment: Mar 2023
- Lead investor: 71%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/kaifulee
- X (Twitter): http://twitter.com/kaifulee

Kai-Fu Lee is a Series B investor at Sinovation Ventures in Beijing focused on Medical and Manufacturing. Kai-Fu Lee is the Chairman and CEO of Sinovation Ventures and President of Sinovation Venture’s Artificial Intelligence Institute. Sinovation Ventures, managing US$1.7 billion dual currency investment funds, is a leading technology investment firm focusing on developing the next generation of Chinese high-tech companies. Prior to foundingSinovation in 2009, Kai-Fu Lee was the President of Google China. Previously, he held executive positions at Microsoft, SGI, and Apple. Kai-Fu Lee received his Bachelor degree from Computer Science from Columbia University, Ph.D. from Carnegie Mellon University, as well as Honorary Doctorate Degrees from both Carnegie Mellon and the City University of Hong Kong. He is also a Fellow of the Institute of Electrical and Electronics Engineers (IEEE). Kai-Fu Lee is the author of seven top selling books in Chinese and launching new book AI Superpowers (www.aisuperpowers.com/) internationally in fall 2018, and has over 50 million followers on social media.In the field of artificial intelligence, Kai-Fu Lee founded Microsoft Research China, which was named as the hottest research lab by MIT Technology Review. Later renamed Microsoft Research Asia, this institute trained the great majority of AI leaders in China, including CTOs or AI heads at Baidu, Tencent, Alibaba, Lenovo, Huawei, and Haier. While with Apple, Kai-Fu Lee led AI projects in speech and natural language, which have been featured on Good Morning America on ABC Television and the front page of Wall Street Journal. He has authored 10 U.S. patents, and more than 100 journal and conference papers. Altogether, Kai-Fu Lee has been in artificial intelligence research, development, and investment for more than 30 years.

## Contacts

5 contacts available for Kai-Fu Lee: work email, personal email, work phone, personal phone and socials. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-email/kai-fu-lee?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $2.1M–$52M |
| Series B | $14M–$62M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 21% |
| Manufacturing | 3 | 21% |
| Artificial Intelligence | 3 | 21% |
| Internet | 2 | 14% |
| Software | 2 | 14% |

28 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series B | 6 | 43% |
| Series A | 3 | 21% |
| Seed | 2 | 14% |
| Angel | 1 | 7% |
| Series C | 1 | 7% |

6 stages tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Project AI 2.0 | Project AI 2.0 is a large language model platform, dedicated to building a brand new AI2.0 platform and AI-first productivity applications. |  |  | Mar 19, 2023 |  |
| Project AI 2.0 | Project AI 2.0 is a large language model platform, dedicated to building a brand new AI2.0 platform and AI-first productivity applications. |  | Seed | Mar 19, 2023 |  |
| J-Elephant | J-Elephant develops intelligent mobile robot products and industrial automation products. J-Elephant develops forklift AMR, providing flexible manufacturing internal logistics solutions for clients in the manufacturing industry. |  | Angel | Apr 27, 2022 |  |
| Elixir Clinical Research | Elixir Clinical Research is a technology-based full-featured clinical CRO. | $52M | Series A | Apr 22, 2022 |  |
| Kilala | Kilala has a product line of color pupils and its surrounding areas to meet the full range of needs of customers. | $61.7M | Series B | Aug 17, 2021 |  |
| MediTrust Health | MediTrust Health is a leading medical innovation payment service brand in China. |  | Series B | Mar 05, 2021 |  |
| Defeng Technology | Defeng Technology is dedicated to providing cloud service, digital twin, PHM, faults diagnosis, safety production early warning and pre-judgment system, digital application and other services for large energy and power companies, petrochemical companies, tobacco companies and manufacturing companies. | $11.3M | Series A | Jun 22, 2020 |  |
| Vedeng | Vedeng provides a platform connecting upstream manufacturers with medical equipment dealers and private clinics. At present, the firm has established a comprehensive digital infrastructure including front-end marketing, procurement systems, logistics, after-sales service and back-end commodity databases, covering 970,000 grassroots and privatemedical customers. | $14.1M | Series B | May 11, 2020 |  |
| Hexiaoxiang | Hangzhou Hexiang Network Technology Co., Ltd., established in May 2017, with the mission of “providing effective and interesting universal education for children”. It is an online education focusing on quality education for children aged 3-12. the company. Adopting the “AI+ Education” model, it integrates innovative technologies such as imagerecognition, voice assessment, intelligent matching, human-computer interaction and big data analysis, and independently develops courses. With the core of "Large Language Comprehensive Literacy", we have launched star products such as writing, calligraphy and fine arts, and are committed to helping children improve their comprehensive quality. | $28M | Series B | Aug 26, 2019 |  |
| Zhuiyi Technology | Zhuiyi Technology develops an artificial intelligence based chatbot for interactions between humans and enterprises. The company offers YiBot, which focuses on deep learning and natural language processing in customer service, big data analysis, and personalized services. The company caters to finance, Internet, tourism, retail, real estate, andeducation sectors. The company is based in Shenzhen, China. | $41M | Series C | Apr 02, 2019 |  |

10 of 14 investments shown.

## Co-investors
- [Gaorong Capital](https://shizune.co/investors/profile/banyan-capital) — VC Fund, 2 deals together
- [GGV Capital](https://shizune.co/investors/profile/ggv-capital) — VC Fund, 2 deals together
- [5Y Capital](https://shizune.co/investors/profile/morningsidevc) — VC Fund, 2 deals together
- [Ant Group](https://shizune.co/investors/profile/ant-group) — VC Fund, 1 deal together
- [BAI capital](https://shizune.co/investors/profile/bertelsmann-asia-investments) — VC Fund, 1 deal together
- [BioTrack Capital](https://shizune.co/investors/profile/biotrack-capital) — VC Fund, 1 deal together

## About Sinovation Ventures

VC Fund · Beijing, China

Sinovation Ventures is a full-service venture capital firm that actively invests in the Chinese technology market.

5 contacts available at Sinovation Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Anita Huang | Operating Partner and Chief Marketing Officer | https://shizune.co/investors/profile/anita-huang |
| Bob Ren | Executive Director | https://shizune.co/investors/profile/bob-ren-8344 |
| Charles Huang | Venture Partner | https://shizune.co/investors/profile/charles-huang-3 |
| Eagle Zhang | Partner | https://shizune.co/investors/profile/eagle-zhang |
| Hua Wang | Co-Founder & Managing Partner | https://shizune.co/investors/profile/hua-wang |

## Similar investors

### Similar industry
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [SV Angel](https://shizune.co/investors/profile/sv-angel) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund

### Similar stage
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund
- [FJ Labs](https://shizune.co/investors/profile/fj-labs) — VC Fund

### Similar country
- [IDG Capital](https://shizune.co/investors/profile/idg-capital-partners) — VC Fund
- [Qiming Venture Partners](https://shizune.co/investors/profile/qiming-venture-partners) — VC Fund
- [HSG](https://shizune.co/investors/profile/sequoia-capital-china) — VC Fund

## Featured in investor lists
- [Gaming Angel Investors in China](https://shizune.co/investors/gaming-angel-investors-china)
- [Media (entertainment) Angel Investors in China](https://shizune.co/investors/media-entertainment-angel-investors-china)
- [Media (entertainment) Angel Investors in China](https://shizune.co/investors/media-entertainment-angel-investors-china)

## FAQ

### What does Kai-Fu Lee invest in?

Kai-Fu Lee invests primarily in Medical, Manufacturing and Artificial Intelligence startups, most often at Series B and Series A stage. Most of the 14 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Kai-Fu Lee's check size?

Kai-Fu Lee typically joins rounds of $2.1M–$52M at Series A and $14M–$62M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Kai-Fu Lee participates in.

### How do I contact Kai-Fu Lee?

Public channels for Kai-Fu Lee include LinkedIn and X (Twitter). For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### When did Kai-Fu Lee last invest?

The most recent investment recorded for Kai-Fu Lee closed in Mar 2023. Shizune tracks 14 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co